Therapy-related B-cell acute lymphoblastic leukemia (B-ALL), a rare form of acute lymphoblastic leukemia (ALL), may develop in patients receiving cytotoxic treatments for a prior malignancy, according ...

In the latest move to cement its “immunology powerhouse” status, Sanofi is handing ove | The CD20-directed antibody, dubbed ...

Artiva Biotherapeutics' CEO Fred Aslan, MD, discusses two ongoing trials for autoimmunity indications in the US and how AlloNK differs from traditional B-cell depletion strategies.

Then, they tested how well suppressor cells carrying different payloads could counteract cytotoxic CAR T cells in vitro ... of these synthetic T cells with other antibodies and B cells. The ...

B cells from the immune system produce antibodies that recognize and neutralize dengue viral particles, and cytotoxic T cells recognize and kill cells that are infected with the virus. People who ...

"Cytotoxic agents from nature lead to an increased incorporation of polyunsaturated fatty acids into the membrane of cancer cells. This makes them more susceptible to ferroptosis, a type of cell ...

to induce donor-specific T-cell-mediated cytotoxic responses and trigger acute rejection of an allogeneic skin graft. The indirect allorecognition pathway is required for B-cell activation and ...

Cellular immunity is a protective immune process that involves the activation of phagocytes, antigen-sensitized cytotoxic T cells ... and antitumor activity in B cell malignancies and multiple ...